Pharmaceutical Options for Stress Urinary Incontinence

被引:0
作者
Andrea D. Juneau
Alex Gomelsky
机构
[1] LSU Health Shreveport,Department of Urology
来源
Current Bladder Dysfunction Reports | 2019年 / 14卷
关键词
Stress urinary incontinence; Estrogen; Duloxetine; Selective androgen receptor modulators;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:357 / 364
页数:7
相关论文
共 224 条
[1]  
Haylen BT(2010)International Urogynecological Association; International Continence Society. An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint report on the terminology for female pelvic floor dysfunction Neurourol Urodyn 29 4-20
[2]  
de Ridder D(2017)Surgical treatment of female stress urinary incontinence: AUA/SUFU guideline J Urol 198 875-883
[3]  
Freeman RM(2018)Risk factors for female pelvic organ prolapse and urinary incontinence Zhong Nan Da Xue Xue Bao Yi Xue Ban 43 1345-1350
[4]  
Swift SE(2015)The urogenital system and the menopause Climacteric 18 18-22
[5]  
Berghmans B(2017)Stress urinary incontinence and endogenous sex steroids in postmenopausal women Neurourol Urodyn 36 121-125
[6]  
Lee J(1984)Prevalence of genito-urinary symptoms in the late menopause Acta Obstet Gynecol Scand 63 257-260
[7]  
Kobashi KC(2009)The relationship between urinary incontinence and steroid hormone levels in perimenopausal women. A report from the Women’s health in the Lund Area (WHILA) study Acta Obst Gynecol Scnad 88 927-932
[8]  
Albo ME(2009)Association between menopausal transition stages and developing urinary incontinence Obstet Gynecol 114 989-998
[9]  
Dmochowski RR(1981)Estrogen receptors in the human female lower urinary tract Am J Obstet Gynecol 141 817-820
[10]  
Ginsberg DA(2000)Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status BJU Int 86 32-38